{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Chronic non-cancer pain and bowel function"],"disease":["Chronic Non-cancer Pain And Bowel Function"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2423319"],"location":["Canada"],"study_start_month":["7"],"keyword":["Study drug 038","controlled-release oxycodone HCl"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A randomised, crossover study of study drug 038 and controlled-release oxycodone HCl tablets in patients with chronic non-cancer pain","description":"Study hypothesis: Study drug 038 will be superior to controlled-release (CR) oxycodone on bowel function and not inferior to CR oxycodone in pain control in patients with chronic non-cancer pain.\nAs of 13/08/2010 this record was updated to include an extended end date; the initial anticipated end date at the time of registration was 15/09/2009. \nAs of 10/01/2011 this record was again updated to include an extended end date; the previous anticipated end date at the time of registration was 31/03/2011.\nPrimary outcome(s): Pain intensity and bowel function measured during the last week of treatment in each phase.","dates":{"creation":"2008-07-15"},"accession":"2423319","cross_references":{"ISRCTN":["ISRCTN76170309"]}}